Best Short-Term Stocks in February 2025 Based on 1yr Returns: Trent, M&M, Zomato & More

In the dynamic world of the stock market, short-term investments can offer opportunities, especially for those looking to capitalise on market fluctuations. This approach focuses on buying and selling stocks within a short period. In this article, check the best short-term stocks in February 2025, based on the 1-yr returns and also learn the benefits and risks of investing in short-term stocks.

Best Short-Term Stocks in February 2025 – Based on 1yr Returns

Name 1Y Return (%) ↓ Market Cap (₹ in crore) PE Ratio
Trent Ltd 89.62 2,04,415.95 137.49
Mahindra and Mahindra Ltd 86.67 3,82,424.28 33.94
Zomato Ltd 69.84 2,12,609.72 605.73
Divi’s Laboratories Ltd 63.99 1,61,836.28 101.15
Bharat Electronics Ltd 56.57 2,07,963.21 52.19
Vedanta Ltd 54.13 1,70,966.30 40.33
Bharti Airtel Ltd 49.34 9,94,278.72 133.16
Info Edge (India) Ltd 48.70 99,709.64 173.35
Bajaj Holdings and Investment Ltd 40.93 1,30,612.39 17.97
Eicher Motors Ltd 40.13 1,49,404.93 37.34

Note: The best short-term stocks list provided here is as of February 5, 2025. The stocks are picked from the Nifty 100 universe and sorted based on the 1-yr returns.

Overview of the Best Short-Term Stocks in February 2025

1. Trent Ltd

Trent is involved in the retailing of apparel, accessories, footwear, and more. In Q2 FY25, the company reported revenues, including GST, of ₹4,394 crore, reflecting a 39% growth compared to ₹3,164 crore in Q2 FY24 and a CAGR of 37% over Q2 FY20. The Profit Before Tax (PBT) for Q2 FY25 stood at ₹467 crore, marking an increase of 49% from ₹314 crore in Q2 FY24 and showcasing a CAGR of 65% over Q2 FY20.

Key Metrics:

  • ROE: 43.95%
  • ROCE: 40.72%

2. Mahindra and Mahindra Ltd

Mahindra & Mahindra Ltd is amongst the most diversified automobile companies in India with a presence across 2-wheelers, 3-wheelers, PVs, CVs, tractors and earthmovers. In Q2 FY25, the company reported consolidated revenue of ₹37,924 crore, reflecting a 10% year-on-year growth compared to ₹34,436 crore in Q2 FY24. The Profit After Tax (PAT) stood at ₹3,171 crore, showcasing a 35% increase from ₹2,348 crore in the same quarter of the previous year.

Key Metrics:

  • ROE: 15.37%
  • ROCE: 14.74%

3. Zomato Ltd

Zomato is a prominent online food service platform, known for its extensive offerings such as food delivery, dining-out services, and more. For the quarter ending December 31, 2024, the company reported that the Gross Order Value (GOV) for the B2C business reached ₹20,206 crore, marking a 57% increase. Adjusted revenue stood at ₹5,746 crore, reflecting a 58% growth, while adjusted EBITDA surged by 128% to ₹285 crore.

Key Metrics:

  • ROE: 1.76%
  • ROCE: 1.71%

4. Divi’s Laboratories Ltd

Divi’s Laboratories Ltd is involved in the manufacturing and exporting of APIs, intermediates and nutraceutical ingredients. The company reported a consolidated total income of ₹2,401 crores for the quarter ending December 31, 2024, compared to ₹1,950 crores in the same quarter last year. The profit after tax (PAT) for the quarter stood at ₹589 crores, up from ₹358 crores in the corresponding period of the previous year.

Key Metrics:

  • ROE: 12.15%
  • ROCE: 15.28%

5. Bharat Electronics Ltd

Bharat Electronics Ltd (BEL) is involved in the manufacturing and supply of electronic equipment and systems to the defence sector. It is a Navratna Defence PSU. The company also has a limited presence in the civilian market. The company recorded a turnover of ₹5,643.25 crore in the third quarter of FY 2024-25, marking a growth of 36.97% compared to ₹4,120.10 crore in the same period last year. The PAT for the quarter stood at ₹1,316.06 crore, reflecting a 47.33% increase from ₹893.30 crore reported in the corresponding period of the previous year.

Key Metrics:

  • ROE: 26.37%
  • ROCE: 30.17%

Best Short-Term Mid-Cap Stocks in Feb 2025 – Based on 1yr Returns

Name 1Y Return (%) ↓ Market Cap (₹ in crore)
Dixon Technologies (India) Ltd 137.56 89,708.26
BSE Ltd 116.28 75,341.68
Mazagon Dock Shipbuilders Ltd 110.12 88,592.33
PB Fintech Ltd 77.23 78,159.28
Bharti Hexacom Ltd 69.19 69,005

Note: The best short-term stocks list provided here is as of February 5, 2025. The stocks are picked from the Nifty Midcap 100 universe. The ROE and ROCE are positive and sorted based on the 1-yr returns.

Best Short-Term Small-Cap Stocks in Feb 2025 – Based on 1yr Returns

Name 1Y Return (%) ↓ Market Cap (₹ in crore)
Aegis Logistics Ltd 90.86 26,632.13
Garden Reach Shipbuilders & Engineers Ltd 73.34 17,431.95
Blue Star Ltd 72.64 41,474.56
Firstsource Solutions Ltd 66.17 23,010.17
Triveni Turbine Ltd 63.08 18,231.83

Note: The best short-term stocks list provided here is as of February 5, 2025. The stocks are picked from the Nifty Smallcap 100 universe. The ROE and ROCE are positive and sorted based on the 1-yr returns.

Benefits of Investing in Short-Term Stocks

  • Quick Returns: Short-term investments can allow investors to capitalise on market fluctuations and earn within a short duration.
  • Liquidity: Short-term stocks are easier to buy and sell, offering higher liquidity for investors needing immediate access to funds.
  • Market Opportunities: Rapid price movements create opportunities to benefit from news events, earnings reports, or market trends.
  • Diversification: Short-term investments can complement long-term investments, helping investors balance their portfolios.

Risks of Investing in Short-Term Stocks

  • Market Volatility: Prices of short-term stocks can be highly volatile, leading to sudden losses.
  • Transaction Costs: Frequent buying and selling incur brokerage fees, reducing net gains.
  • Emotional Decisions: Quick trades may lead to impulsive decisions, increasing the likelihood of losses.

Conclusion

Short-term investments can be beneficial to achieve immediate goals, such as planning a trip or purchasing a car. It’s vital to assess your investment objectives and risk tolerance before making a decision. Additionally, evaluate the company’s operations, financial health, and future outlook.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Union Budget 2025: What is PM SVANidhi, Eligibility & What’s New for Street Vendors?

During the Union Budget 2025 Presentation on February 1, 2025, the Union Finance Minister, Nirmala Sitharaman, announced significant changes to the PM SVANidhi Scheme. The Scheme aims to further support street vendors who have been among the hardest hit by the COVID-19 pandemic. This revamped initiative is set to provide enhanced loan facilities, UPI-linked credit cards with a ₹30,000 limit, and capacity-building support.

She announced, “PM SVANidhi Scheme has benefitted more than 68 lakh street vendors, giving them respite from high-interest informal sector loans. Building on this success the scheme will be revamped with enhanced loans from banks, UPI-linked credit cards with ₹30,000 limit and capacity-building support.”

What is PM SVANidhi?

The Prime Minister Street Vendor’s AtmaNirbhar Nidhi (PM SVANidhi) was launched by the Ministry of Housing and Urban Affairs to economically uplift and empower street vendors. It provides collateral-free working capital loans to street vendors to help them resume and grow their businesses in urban and peri-urban areas.

The scheme targets street vendors who were vending on or before March 24, 2020, and facilitates loans in three tranches:

  1. First Tranche: Loan up to ₹10,000 for a tenure of 12 months.
  2. Second Tranche: Loan between ₹15,000 and ₹20,000 for a tenure of 18 months.
  3. Third Tranche: Loan between ₹30,000 and ₹50,000 for a tenure of 36 months.

These loans are designed to be affordable and inclusive, addressing the needs of vendors who would otherwise rely on high-interest informal loans.

Benefits and Incentives of PM SVANidhi Scheme

The scheme offers several incentives to encourage timely repayment and digital transactions:

  • Interest Subsidy: 7% per annum on regular repayment of loans.
  • Cashback Incentive: Up to ₹1,200 per year for undertaking prescribed digital transactions.
  • Eligibility for Enhanced Loans: Regular repayment makes vendors eligible for the next tranche of loans.

Eligibility Criteria of PM SVANidhi Scheme

Street vendors who meet the following criteria can avail of the scheme:

  1. Possess a Certificate of Vending or Identity Card issued by Urban Local Bodies (ULBs).
  2. Identified in ULB surveys but without a Certificate of Vending; provisional certificates can be issued through an IT-based platform.
  3. Vendors left out of surveys but issued a Letter of Recommendation (LoR) by the ULB/Town Vending Committee (TVC).
  4. Vendors from surrounding peri-urban or rural areas vending within ULB limits and possessing an LoR.

How to Apply to the PM SVANidhi Scheme?

Street vendors can apply for loans directly through the PM SVANidhi portal or visit a nearby Common Service Centre (CSC). Pre-application steps include:

  • Understanding loan requirements.
  • Ensuring the mobile number is linked to Aadhaar.
  • Checking eligibility under the scheme rules.

Under the PM SVANidhi Scheme, credit is provided by various lending institutions, including Scheduled Commercial Banks, Regional Rural Banks, Small Finance Banks, Cooperative Banks, Non-Banking Financial Companies (NBFCs), Micro-Finance Institutions (MFIs), and Self-Help Group (SHG) Banks.

Conclusion 

The PM SVANidhi scheme has proven to be a lifeline for street vendors, enabling them to restart their businesses, reduce dependency on informal loans, and improve their economic well-being. With enhanced credit facilities and digital integration during Union Budget 2025, the scheme will continue to empower street vendors and contribute to the growth of India’s informal economy.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Coal Sector Leads Growth Among Eight Core Industries in December 2024

The Ministry of Coal recently on February 3, 2025, announced that the coal sector demonstrated the highest growth among the eight core industries in December 2024, according to the Index of Eight Core Industries (ICI) released by the Ministry of Commerce & Industry. The coal index reached 215.1 points, a 5.3% increase from 204.3 points in December 2023.

Robust Growth in April-December 2024 Period

During April to December 2024, the coal industry’s index grew to 177.6 points from 167.2 points in the same period of the previous year. This represents a robust 6.2% growth, the highest among all eight core industries.

The ICI measures the combined and individual production performance of eight key industries: cement, coal, crude oil, electricity, fertilizers, natural gas, refinery products, and steel.

Combined Index Growth Highlights Coal’s Contribution

The Combined Index of Eight Core Industries showed a 4.0% year-on-year growth in December 2024. For the April-December 2024 period, the index rose by 4.2% compared to the same period in FY 2023-24. The coal sector’s strong performance played a pivotal role in this industrial expansion.

Coal Production Surge Fuels Growth

The coal sector’s remarkable growth is attributed to a significant increase in production. During April-December 2024, coal production reached 726.31 million tonnes (MT), up from 684.47 MT during the same period last year. This 6.1% rise reflects the sector’s ability to meet the growing energy and manufacturing demand.

Coal India Ltd

Coal India Limited, a prominent player in the coal sector, has announced its financial results for 9M FY25. The company recorded a total income of ₹1,08,450 crore, a decline of 2% compared to ₹1,10,639 crore during the same period last year. Profit after tax stood at ₹25,710 crore, reflecting a decrease of ₹3,129 crore or 11% from ₹28,839 crore in 9M FY24.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Union Budget 2025: Textile Sector Gets ₹5,272 Crore; Focus on MSMEs & Exports

The Union Budget 2025, presented on February 1, 2025, announced significant measures to boost India’s textile sector, which is primarily driven by MSMEs and contributes substantially to the economy.

The Ministry of Textiles received a budget outlay of ₹5,272 crores for 2025-26, marking a 19% increase from the ₹4,417.03 crores allocated in the previous budget.

Cotton Mission: Enhancing Productivity

One of the key initiatives is the launch of a 5-year Cotton Mission aimed at addressing stagnant cotton productivity, particularly for extra-long staple varieties. The Mission emphasises providing Science & Technology support to farmers, in alignment with the 5F principle.

This initiative aims to increase farmers’ income, ensure a steady supply of quality cotton, and reduce reliance on imports. By boosting domestic cotton productivity, the government seeks to stabilize raw material availability and enhance the global competitiveness of India’s textile sector, where MSMEs drive 80% of capacity.

Incentives for Technical Textiles

The Budget introduced measures to promote the domestic production of technical textiles such as agro-textiles, medical textiles, and geo-textiles. Two additional types of shuttle-less looms were added to the list of fully exempted textile machinery.

Duties on Shuttle-less Rapier Looms (below 650 meters per minute) and Air Jet Looms (below 1,000 meters per minute) have been reduced to nil from the previous 7.5%. This reduction will lower the cost of high-quality imported looms, facilitating modernisation and capacity building in the weaving sector. It also aligns with the “Make in India” initiative, boosting the technical textile industry.

Custom Duty Adjustments

The Basic Custom Duty on knitted fabrics, covering nine tariff lines, has been increased from 10% or 20% to 20% or ₹115 per kg, whichever is higher. This measure is aimed at curbing cheap imports and improving the competitiveness of Indian knitted fabric manufacturers.

Boost for Handicrafts and MSMEs

To facilitate handicraft exports, the permissible export period has been extended from six months to one year, with a possible extension of another three months. Additionally, nine items, including wool polish materials and cattle horn, have been added to the list of duty-free raw material imports meant for export production.

Other MSME-focused measures include a National Manufacturing Mission, Export Promotion Mission, Bharat Trade Net, and Fund of Funds. These initiatives are expected to uplift textile MSMEs by promoting employment, entrepreneurship, and a conducive environment for growth.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Rallis India Share Price Rise 4.05%; SBI Mutual Fund Boosts Stake in Rallis India to 9.17%

On February 4, 2025, Rallis India informed the exchanges that SBI Mutual Fund has increased its shareholding in their company under its various schemes. This marks a rise of 2% from its previous disclosure made as per Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. As of December 31, 2024, SBI Mutual Fund’s holding stood at 7.0577% of Rallis India’s paid-up share capital.

Recently, SBI Mutual Fund purchased 1,492,759 additional shares, representing 0.7676% of Rallis India’s paid-up share capital. Following this acquisition, the total shareholding of SBI Mutual Fund across its schemes has reached 17,826,452 shares, which is equivalent to 9.1667% of Rallis India’s paid-up share capital as of January 31, 2025.

Rallis India Share Price Performance

On February 5, 2025, Rallis India share price opened at ₹238.01, up from its previous close of ₹236.65. At 10:16 AM, the share price of Rallis India was trading at ₹246.24, up by 4.05% on the NSE.

About Rallis India Ltd

Rallis India, a Tata Group company with a legacy spanning over 150 years, specialises in manufacturing agrochemicals. The company operates across the entire agriculture input value chain, offering products ranging from seeds to organic plant growth nutrients. Additionally, Rallis engages in contract manufacturing for global corporations.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

MAS Financial Services Interim Dividend Record Date is Today, February 5, 2025

MAS Financial Services Limited’s Board of Directors has declared and approved an interim dividend of ₹1 (10%) per equity share of face value ₹10 each.

On February 5, 2025, MAS Financial Services share price opened at ₹250.65, down from its previous close of ₹252.25. At 9:39 AM, the share price of MAS Financial Services was trading at ₹254.40, up by 1.25% on the NSE. Notably, the stock price touched its 52-week high at ₹229.40 on January 27, 2025.

MAS Financial Services Dividend Record Date

On January 29, 2025, the company’s Board of Directors declared an interim dividend of ₹1 per equity share, representing 10% of the face value of ₹10. The record date for the interim dividend is set as Wednesday, February 5, 2025.

Q3 FY 2025 Financial Highlights

MAS Financial Services Limited, on a consolidated basis, reported Assets Under Management (AUM) of ₹12,378.80 crore and Profit After Tax (PAT) of ₹80.21 crore for the quarter ended December 31, 2024. This marks a growth of 21.17% in AUM and 24.83% in PAT compared to ₹10,215.05 crore and ₹64.27 crore, respectively, for the same period in 2023. The consolidated disbursement during the quarter was ₹3,227.72 crore.

About MAS Financial Services Ltd

MAS Financial Services Limited is a non-deposit-taking NBFC registered with the RBI. It is involved in providing retail financing products for MSMEs, home loans, two-wheeler loans, used car loans and commercial vehicle loans.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Sun Pharma Interim Dividend of ₹10.50 Record Date Tomorrow, February 6, 2025

Sun Pharmaceutical Industries Limited’s Board of Directors has declared and approved an interim dividend of ₹10.50 per equity share.

On February 5, 2025, Sun Pharma share price opened at ₹1,773.80, up from its previous close of ₹1,765.25. However, at 9:36 AM, the share price of Sun Pharmaceutical Industries was trading at ₹1,753.50, down by 0.67% on the NSE.

Sun Pharmaceutical Industries Dividend Record Date

The company has declared an interim dividend of ₹10.50 (Rupees Ten and Paise Fifty) per equity share of ₹1 (Rupee One) each for the financial year 2024-25. As announced on January 16, 2025, the record date for determining eligibility for the interim dividend is February 6, 2025. The payment of the interim dividend will be made on or before February 20, 2025.

9M FY 2025 Financial Highlights

Gross sales for the period reached ₹3,92,257 million, reflecting a growth of 9.1%. India formulation sales stood at ₹1,27,100 million, recording an impressive 13.7% increase. Meanwhile, US formulation sales amounted to $1,457 million, up by 5.7%, showcasing steady growth in international markets.

EBITDA, including other operating revenues, surged by 15.7% to ₹115,556 million, achieving an EBITDA margin of 29.2%. Net profit for the first nine months of FY25 was ₹87,792 million. On a like-for-like basis, the adjusted net profit stood at ₹90,953 million, marking a 24.3% year-on-year growth.

About Sun Pharmaceutical Industries Ltd

Sun Pharma is a global leader in speciality generics, offering a wide range of products in Specialty, Generics, and Consumer Healthcare. It is India’s largest pharmaceutical company and ranks among the top generic manufacturers in the US and emerging global markets.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Godrej Properties Share Price in Focus; Sets New Record with ₹19,281 Crore Bookings in 9M FY25

Godrej Properties Limited recently announced its unaudited financial results for the quarter and nine months ended December 31, 2024.

On February 5, 2025, Godrej Properties share price opened at ₹2,451.00, up from its previous close of ₹2,389.85. At 9:31 AM, the share price of Godrej Properties was trading at ₹2,428.10, up by 1.60% on the NSE.

Sales Highlights

In 9M FY25, the company achieved its highest-ever booking value of ₹19,281 crore, a 48% year-on-year (Y-o-Y) growth, from the sale of 18.21 million sq. ft. of area, reflecting a 54% volume growth. This marks the highest 9-month booking value and area sold by Godrej Properties and any Indian real estate developer to date.

For Q3 FY25, booking value stood at ₹5,446 crore from the sale of 4.07 million sq. ft., a 5% decline Y-o-Y but a 5% growth quarter-on-quarter. This was the sixth consecutive quarter with booking values exceeding ₹5,000 crore. The company has already achieved 71% of its annual guidance for booking value in FY25.

Notably, the Mumbai Metropolitan Region (MMR) recorded a booking value of ₹5,155 crore, a 104% Y-o-Y growth, while Bengaluru reported ₹4,807 crore, a 145% YoY growth during 9M FY25. Godrej Properties launched seven new projects and phases across four cities during the quarter.

Business Development

The company added 4 new projects in Q3 FY25 with an estimated saleable area of 5.9 million sq. ft. and an expected booking value of ₹10,800 crore. In 9M FY25, 12 new projects were added, covering a total saleable area of approximately 16.9 million sq. ft. with an estimated booking value potential of ₹23,450 crore, surpassing the full-year guidance of ₹20,000 crore.

Financial Performance

In Q3 FY25, total income surged by 133% to ₹1,222 crore, EBITDA grew by 85% to ₹280 crore, and net profit increased by 161% to ₹163 crore compared to Q3 FY24.

For 9M FY25, total income grew by 74% to ₹4,203 crore, EBITDA rose by 144% to ₹1,336 crore, and net profit jumped 301% to ₹1,018 crore compared to the same period last year.

Commenting on the performance of Q3 FY2025, the Executive Chairperson of Godrej Properties Limited, Mr Pirojsha Godrej, said, “Godrej Properties delivered a record-breaking calendar year 2024 with its highest ever bookings, collections, operating cashflows, earnings and deliveries. The third quarter of financial year 2025 was the 6th consecutive quarter of more than INR 5,000 crores in bookings underlying the sectoral tailwinds for the residential real estate sector in India.”

He further added, “With a robust launch pipeline, strong balance sheet, and resilient demand, we are on track to surpass our bookings guidance of INR 27,000 cores in FY25 while also achieving our highest-ever cash collections, deliveries, earnings and operating cash flow. We remain focused on building scale through continued market share gains and margin expansion.”

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Dr Agarwals Healthcare Share Price Opens at ₹402 on Listing Day, Feb 4

Dr Agarwals Healthcare IPO opened for subscription on January 29, 2025, and closed on January 31, 2025.

It was a book-built issue of ₹3,027.26 crore. The issue was a combination of a fresh issue of 0.75 crore shares and an offer for sale of 6.78 crore shares. The Dr Agarwals Healthcare IPO price band was set at ₹382 to ₹402 per share.

On Day 3 of subscription, January 31, as of 5:04 PM, Dr Agarwals Healthcare IPO was subscribed 1.49 times. QIBs subscribed 4.41x, NIIs subscribed 0.39x, and retail investors subscribed 0.42x.

The share allotment was finalised on Monday, February 3, 2025, and the shares were listed on BSE and NSE on Tuesday, February 4, 2025.

Dr Agarwals Healthcare Share Price

On the listing day, on the NSE, Dr Agarwals Healthcare share price (NSE: AGARWALEYE) opened at ₹402.00, the same as its issue price of ₹402.00. The share price closed at ₹400.00, down by 0.50%. The stock touched its day’s high at ₹412.90 and day’s low at ₹370.20. The company’s market cap was ₹12,635.19 crore.

On the BSE, Dr Agarwals Healthcare share price closed at ₹401.55, up by 1.17%. The opening price was ₹396.90.

About Dr. Agarwal’s Health Care Limited

Dr Agarwals provides a comprehensive range of eye care services, such as cataract, refractive, and other surgeries. The company also provides consultations, diagnoses, non-surgical treatments, optical products, contact lenses, accessories, and eye care-related pharmaceutical products.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Stocks To Watch Today on February 5, 2025: Tata Power, Lemon Tree Hotels, Sun Pharma & More in Focus

On Wednesday, February 5, 2025, the Indian benchmark indices Sensex and Nifty 50 are expected to open higher, following gains in global markets. Check out a few stocks that might be in focus during the trading session.

  • Tata Power

Tata Power‘s Q3 consolidated net profit surged to ₹1,030 crore, up from ₹953 crore year-on-year (Y-o-Y). Revenue climbed to ₹15,400 crore, compared to ₹14,651 crore. EBITDA jumped to ₹3,352 crore, rising from ₹2,417 crore, while the EBITDA margin improved significantly to 21.78% from 16.50%.

  • Lemon Tree Hotels

Lemon Tree Hotels reported a sharp rise in Q3 consolidated net profit, which increased to ₹62.5 crore from ₹35.4 crore Y-o-Y and ₹29.6 crore sequentially. Revenue climbed to ₹360 crore, up from ₹289 crore Y-o-Y. EBITDA rose to ₹184 crore from ₹142 crore, with the EBITDA margin expanding to 51.86% from 48.80%.

  • Metropolis Healthcare

Metropolis Healthcare‘s Q3 consolidated net profit improved to ₹31.4 crore, compared to ₹27.15 crore in the previous year. Revenue increased to ₹323 crore, up from ₹290 crore. EBITDA stood at ₹72 crore, higher than ₹64.8 crore, while the EBITDA margin remained stable at 22.31%, marginally up from 22.28%.

  • Sun Pharma

Sun Pharma announced that Philogen has completed patient enrollment for the Phase III Fibrosarc trial in soft tissue sarcoma.

  • Whirlpool of India

Whirlpool of India‘s Q3 consolidated net profit jumped to ₹44 crore, compared to ₹28 crore Y-o-Y. Revenue expanded to ₹1,700 crore, rising from ₹1,526 crore. EBITDA grew to ₹69.3 crore, up from ₹62.7 crore, while the EBITDA margin stood at 4.06%, slightly lower than 4.08%.

  • Indian Energy Exchange (IEX)

Indian Energy Exchange (IEX) recorded a traded volume of 10,910 MU in January, marking a 16% increase Y-o-Y. The average DAM price was ₹4.43/unit, reflecting a 24% decline from the previous year.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.